167 related articles for article (PubMed ID: 28642494)
1. Proteome profiling reveals novel biomarkers to identify complicated parapneumonic effusions.
Wu KA; Wu CC; Chen CD; Chu CM; Shih LJ; Liu YC; Wang CL; Lin HH; Yang CY
Sci Rep; 2017 Jun; 7(1):4026. PubMed ID: 28642494
[TBL] [Abstract][Full Text] [Related]
2. Combined serum biomarkers in the noninvasive diagnosis of complicated parapneumonic effusions and empyema.
Wu KA; Wu CC; Liu YC; Hsueh PC; Chin CY; Wang CL; Chu CM; Shih LJ; Yang CY
BMC Pulm Med; 2019 Jun; 19(1):108. PubMed ID: 31215423
[TBL] [Abstract][Full Text] [Related]
3. Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema.
Chen SC; Chen W; Hsu WH; Yu YH; Shih CM
Lung; 2006; 184(3):141-5. PubMed ID: 16902838
[TBL] [Abstract][Full Text] [Related]
4. Pleural cytokines MIF and MIP-3α as novel biomarkers for complicated parapneumonic effusions and empyema.
Yang CY; Kuo YH; Chen M; Wang CL; Shih LJ; Liu YC; Hsueh PC; Lai YH; Chu CM; Wu CC; Wu KA
Sci Rep; 2021 Jan; 11(1):1763. PubMed ID: 33469074
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Pleural Fluid Lactate for Diagnosis and Management of Parapneumonic Pleural Effusion.
Santotoribio JD; Alnayef-Hamwie H; Batalha-Caetano P; Perez-Ramos S; Pino MJ
Clin Lab; 2016 Sep; 62(9):1683-1687. PubMed ID: 28164581
[TBL] [Abstract][Full Text] [Related]
6. Pentraxin-3: A novel biomarker for discriminating parapneumonic from other exudative effusions.
Ozsu S; Abul Y; Mentese A; Bektas H; Uzun A; Ozlu T; Porcel JM
Respirology; 2013 May; 18(4):657-62. PubMed ID: 23286371
[TBL] [Abstract][Full Text] [Related]
7. Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated non-purulent from uncomplicated parapneumonic effusions.
Porcel JM; Galindo C; Esquerda A; Trujillano J; Ruiz-González A; Falguera M; Vives M
Respirology; 2008 Jan; 13(1):58-62. PubMed ID: 18197912
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of the British Thoracic Society and the American College of Chest Physicians guidelines in predicting pleural drainage of non-purulent parapneumonic effusions.
Manuel Porcel J; Vives M; Esquerda A; Ruiz A
Respir Med; 2006 May; 100(5):933-7. PubMed ID: 16253494
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of C-reactive protein in parapneumonic effusions.
Skouras V; Boultadakis E; Nikoulis D; Polychronopoulos V; Daniil Z; Kalomenidis I; Gourgoulianis KI
Respirology; 2012 Feb; 17(2):308-14. PubMed ID: 21995428
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha in pleural fluid: a marker of complicated parapneumonic effusions.
Porcel JM; Vives M; Esquerda A
Chest; 2004 Jan; 125(1):160-4. PubMed ID: 14718436
[TBL] [Abstract][Full Text] [Related]
11. A Simple Method for Differentiating Complicated Parapneumonic Effusion/Empyema from Parapneumonic Effusion Using the Split Pleura Sign and the Amount of Pleural Effusion on Thoracic CT.
Tsujimoto N; Saraya T; Light RW; Tsukahara Y; Koide T; Kurai D; Ishii H; Kimura H; Goto H; Takizawa H
PLoS One; 2015; 10(6):e0130141. PubMed ID: 26076488
[TBL] [Abstract][Full Text] [Related]
12. Role of interleukin-8 in differentiation of uncomplicated from complicated parapneumonic effusion.
Petrusevska Marinkovic S; Kondova Topuzovska I; Milenkovic Z; Kondov G; Bosevska G; Anastasovska A
Prilozi; 2011; 32(1):101-11. PubMed ID: 21822181
[TBL] [Abstract][Full Text] [Related]
13. Pleural fluid lactate as a point-of-care adjunct diagnostic aid to distinguish tuberculous and complicated parapneumonic pleural effusions during initial thoracentesis: Potential use in a tuberculosis endemic setting.
Kho SS; Chan SK; Yong MC; Cheah HM; Lee YG; Tie ST
Respir Investig; 2020 Sep; 58(5):367-375. PubMed ID: 32107195
[TBL] [Abstract][Full Text] [Related]
14. Clinical importance of angiogenic cytokines, fibrinolytic activity and effusion size in parapneumonic effusions.
Chung CL; Hsiao SH; Hsiao G; Sheu JR; Chen WL; Chang SC
PLoS One; 2013; 8(1):e53169. PubMed ID: 23308155
[TBL] [Abstract][Full Text] [Related]
15. Role of tumor necrosis factor-alpha in the differential diagnosis of parapneumonic effusion.
Odeh M; Sabo E; Oliven A; Srugo I
Int J Infect Dis; 2000; 4(1):38-41. PubMed ID: 10689213
[TBL] [Abstract][Full Text] [Related]
16. Serum C-reactive protein as an adjunct for identifying complicated parapneumonic effusions.
Bielsa S; Valencia H; Ruiz-González A; Esquerda A; Porcel JM
Lung; 2014 Aug; 192(4):577-81. PubMed ID: 24913743
[TBL] [Abstract][Full Text] [Related]
17. Pleural fluid cell-free DNA in parapneumonic pleural effusion.
Santotoribio JD; Cabrera-Alarcón JL; Batalha-Caetano P; Macher HC; Guerrero JM
Clin Biochem; 2015 Oct; 48(15):1003-5. PubMed ID: 26234638
[TBL] [Abstract][Full Text] [Related]
18. Pleural-fluid myeloperoxidase in complicated and noncomplicated parapneumonic pleural effusions.
Alegre J; Jufresa J; Segura R; Ferrer A; Armadans L; Aleman C; Marti R; Ruiz E; Fernández de Sevilla T
Eur Respir J; 2002 Feb; 19(2):320-5. PubMed ID: 11866013
[TBL] [Abstract][Full Text] [Related]
19. Utility of measurement of interleukin-1ß and interleukin-8 in the diagnosis of complicated parapneumonic pleural effusions.
San José ME; Ferreiro L; Soneira ME; González-Barcala FJ; Vázquez MC; Golpe A; Valdés L
Am J Clin Pathol; 2014 Oct; 142(4):467-73. PubMed ID: 25239413
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers of infection for the differential diagnosis of pleural effusions.
Porcel JM; Vives M; Cao G; Bielsa S; Ruiz-González A; Martínez-Iribarren A; Esquerda A
Eur Respir J; 2009 Dec; 34(6):1383-9. PubMed ID: 19541708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
